Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission
- PMID: 21896299
- DOI: 10.1016/j.vaccine.2011.08.059
Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission
Abstract
Since the resolution of the World Assembly in 1988 to eradicate polio globally, substantial progress toward this target has been achieved, but the final goal remains elusive. India and other tropical developing countries present a unique challenge because of the much lower oral poliovirus vaccine (OPV) immunogenicity compared to industrialized countries, both in terms of humoral and mucosal immunity. To overcome this challenge, further research is needed to elucidate the causes for the suboptimal OPV immunogenicity, better defining the optimal vaccine schedules and delivery strategies, developing and evaluating adjuvants to boost OPV immunogenicity, and improving the methods for directly measuring mucosal immunity.
Copyright © 2011 World Health Organization. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Anomalous observations on IPV and OPV vaccination.Dev Biol (Basel). 2001;105:197-208. Dev Biol (Basel). 2001. PMID: 11763328
-
Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India.J Infect Dis. 2014 Nov 1;210 Suppl 1:S398-411. doi: 10.1093/infdis/jit844. J Infect Dis. 2014. PMID: 25316861
-
Progress toward interruption of wild poliovirus transmission--worldwide, January 2004-March 2005.MMWR Morb Mortal Wkly Rep. 2005 Apr 29;54(16):408-12. MMWR Morb Mortal Wkly Rep. 2005. PMID: 15858461
-
[Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].Bull Soc Pathol Exot. 2000 Jul;93(3):193-7. Bull Soc Pathol Exot. 2000. PMID: 11030056 Review. French.
-
Epidemiology of poliomyelitis--options and update.Vaccine. 2008 Oct 23;26(45):5767-73. doi: 10.1016/j.vaccine.2008.07.101. Epub 2008 Aug 26. Vaccine. 2008. PMID: 18755232 Review.
Cited by
-
Environmental Surveillance of Poliovirus and Non-polio Enteroviruses in Iran, 2017-2023: First Report of Imported Wild Poliovirus Type 1 Since 2000.Food Environ Virol. 2024 Sep;16(3):391-397. doi: 10.1007/s12560-024-09600-8. Epub 2024 Apr 24. Food Environ Virol. 2024. PMID: 38658427
-
Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic.World J Virol. 2022 Sep 25;11(5):221-236. doi: 10.5501/wjv.v11.i5.221. World J Virol. 2022. PMID: 36188733 Free PMC article. Review.
-
Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application.Pharmaceutics. 2021 Dec 5;13(12):2091. doi: 10.3390/pharmaceutics13122091. Pharmaceutics. 2021. PMID: 34959372 Free PMC article. Review.
-
COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform.Vaccines (Basel). 2021 Feb 18;9(2):171. doi: 10.3390/vaccines9020171. Vaccines (Basel). 2021. PMID: 33670630 Free PMC article. Review.
-
Prosocial polio vaccination in Israel.Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):13138-13144. doi: 10.1073/pnas.1922746117. Epub 2020 May 26. Proc Natl Acad Sci U S A. 2020. PMID: 32457142 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
